World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
42318
World Ranking
11565
National Ranking
5936

Research.com Recognitions

  • 2008 - Member of the National Academy of Medicine (NAM)

Overview

Ira Shoulson is affiliated with Georgetown University in the United States and has a research focus primarily in Medicine, with substantial work in Biochemistry, Genetics, and Molecular Biology. Their published work spans several subfields, notably Neurology, Molecular Biology, Cellular and Molecular Neuroscience, Psychiatry and Mental Health, and Cognitive Neuroscience.

The scientist's research encompasses major topics including Parkinson's Disease Mechanisms and Treatments, Neurological Disorders and Treatments, Genetic Neurodegenerative Diseases, Autism Spectrum Disorder Research, Mitochondrial Function and Pathology, Health Systems, Economic Evaluations, Quality of Life, and RNA Regulation and Disease.

Recent publications by Ira Shoulson include:

  • Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression, 2021, JAMA
  • Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease, 2021, Nature Genetics
  • Genetic modifiers of Huntington disease differentially influence motor and cognitive domains, 2022, The American Journal of Human Genetics
  • Deep Phenotyping of Parkinson's Disease, 2020, Journal of Parkinson s Disease
  • Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience, 2020, Journal of Parkinson s Disease

Frequent co-authors collaborating with Ira Shoulson are:

  • Lana M. Chahine
  • Lakshmi Arbatti
  • Abhishek Hosamath
  • David G. Standaert
  • David Oakes

The researcher has several publications in journals including:

  • Journal of Parkinson s Disease (7 publications)
  • Neurology (2 publications)
  • JAMA (1 publication)
  • Nature Genetics (1 publication)
  • The American Journal of Human Genetics (1 publication)

Ira Shoulson was recognized as a Member of the National Academy of Medicine (NAM) in 2008.

Best Publications

  • A polymorphic DNA marker genetically linked to Huntington's disease

    James F. Gusella;Nancy S. Wexler;P. Michael Conneally;Susan L. Naylor

  • Unified huntington’s disease rating scale: Reliability and consistency

    Karl Kieburtz;John B. Penney;Peter Corno;Neal Ranen

  • Levodopa and the progression of Parkinson's disease.

    Fahn S;Oakes D;Shoulson I;Kieburtz K

  • Variable expression of Parkinson's disease A base‐line analysis of the DAT ATOP cohort

    Joseph Jankovic;Michael P McDermott;Jonathan T Carter;Susan A Gauthier

  • Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

    Clifford W. Shults;David Oakes;Karl Kieburtz;M. Flint Beal

  • Trinucleotide repeat length instability and age of onset in Huntington's disease

    M Duyao;C Ambrose;R Myers;A Novelletto

  • Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial

    R. Holloway;I. Shoulson;K. Kieburtz;M. McDermott

  • Effect of deprenyl on the progression of disability in early Parkinson's disease

    I. Shoulson;S. Fahn;D. Oakes;C. Odoroff

  • Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset

    Nancy S. Wexler;Judith Lorimer;Julie Porter;Fidela Gomez

  • Huntington disease: Clinical care and evaluation

    Ira Shoulson;Stanley Fahn

  • Detection of Huntington’s disease decades before diagnosis: The Predict HD study

    Jane Paulsen;Douglas R Langbehn;Julie C Stout;Elizabeth H Aylward

  • A controlled trial of rasagiline in early Parkinson disease: The tempo study

    Andrew Siderowf;Matthew Stern;Ira Shoulson;Karl Kieburtz

  • Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

    Robert G Holloway;Ira Shoulson;Stanley Fahn;Karl Kieburtz

  • Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease

    Jong-Min Lee;Vanessa C. Wheeler;Michael J. Chao;Jean Paul G. Vonsattel

  • CAG repeat not polyglutamine length determines timing of Huntington’s disease onset

    Jong-Min Lee;Kevin Correia;Jacob Loupe;Kyung-Hee Kim

  • Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa

    John B. Penney;David Oakes;Ira Shoulson;Stanley Fahn

  • NMDA receptor losses in putamen from patients with Huntington's disease

    AB Young;JT Greenamyre;Z Hollingsworth;R Albin

  • Homozygotes for Huntington's disease

    Nancy S. Wexler;Nancy S. Wexler;Anne B. Young;Rudolph E. Tanzi;Helen Travers

  • Rate of functional decline in Huntington’s disease

    K. Marder;H. Zhao;R. H. Myers;M. Cudkowicz

  • Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.

    JT Greenamyre;JB Penney;AB Young;CJ D'Amato

Frequent Co-Authors

Karl Kieburtz
Karl Kieburtz University of Rochester Medical Center
Roger Kurlan
Roger Kurlan Overlook Medical Center
Jane S. Paulsen
Jane S. Paulsen University of Wisconsin–Madison
Michael P. McDermott
Michael P. McDermott University of Rochester
Anthony E. Lang
Anthony E. Lang University of Toronto
Anne B. Young
Anne B. Young Harvard University
Joseph Jankovic
Joseph Jankovic Baylor College of Medicine
Caroline M. Tanner
Caroline M. Tanner University of California, San Francisco
Kenneth Marek
Kenneth Marek Institute for Neurodegenerative Disorders
Marcy E. MacDonald
Marcy E. MacDonald Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but exploring alternative routes or building their credentials, several online nursing and healthcare programs offer flexible and accelerated options. These pathways can provide a faster entrance into healthcare careers while allowing you to continue working or meet family commitments.

For registered nurses seeking advancement, rn to bsn online no clinicals programs are a popular choice. They allow you to earn your Bachelor of Science in Nursing without the need for additional clinical hours. If you are an LPN aiming to move ahead quickly, explore fast track lpn programs online to reduce your time to certification.

Nurses looking to move into leadership, research, or advanced clinical roles may consider doctoral studies. There are accelerated msn to dnp programs and a range of dnp programs online for those who want the highest qualification in nursing practice. These online programs can help broaden your career options or prepare you for specialized roles in the evolving healthcare landscape.

Best Scientists Citing Ira Shoulson

Trending Scientists

Recently Published Articles